期刊文献+

黑曲霉发酵法制备大豆异黄酮苷元工艺初探 被引量:2

Study on production soybean isoflavone aglycon through aspergillus niger fermentation
下载PDF
导出
摘要 利用能产生β-葡萄糖苷酶的黑曲霉作为菌种,对大豆胚芽进行固态发酵,制备大豆异黄酮苷元。考察了几个主要因素对发酵过程中大豆异黄酮苷元产生量的影响,初步探讨了黑曲霉发酵法制备大豆异黄酮苷元的工艺条件。 Aspergillus niger which can secret β-glucosidase was used as the strain for the solid state fermentation to produce soybean isoflavone aglycon from soybean germs. We studied several main factors which can influence the yield of soybean isoflavone aglycon during the fermentation and discussed the parameters of techniques for producing soybean isoflavone aglycon through Aspergillus niger fermentation.
出处 《食品工业科技》 CAS CSCD 北大核心 2006年第11期129-131,共3页 Science and Technology of Food Industry
基金 陕西省自然科学基金项目(2005808)陕西省教育厅专项科研计划项目(05JK150)
关键词 大豆异黄酮 苷元 黑曲霉 发酵 soybean isoflavone aglycon Aspergillus niger, fermentation
  • 相关文献

参考文献7

  • 1Adlercreutz H,Swshadri TR.Isoflavone of soybeans[J].Current Sci,1953,22263~265.
  • 2井乐刚,张永忠.微生物发酵制备大豆异黄酮的研究进展[J].微生物学通报,2003,30(2):86-88. 被引量:27
  • 3Adlercreutz H,Mazur W.Phyto-ostrogens and Western Diseases[J].Animal Medical,1997,29:95.
  • 4Naim M,Gestetner B,Bondi A,et al.Antioxidantive and antiheolytic activites of soybean isoflavones[J].Agric Food Chem,1976,24:1174~1177.
  • 5Messina M,et al.The role of soy products in reducing risk of cancer[J].J of National Cancer Institute,1991,83(8)541~546.
  • 6Shiraiwa W,et al.Composition and content of saponins in soybean seed according to variety cultivation year andmaturity[J].Agric Biol Chem,1991,55(2):323.
  • 7Dinitri Tsangalis,John F Ashton.Development of an isoflavone aglycone-enriched soymilk using soy germ,soy protein isolate and bifidobacteria[J].Food Research international,2004,37:301~312.

二级参考文献2

共引文献26

同被引文献21

  • 1葛喜珍,林强,霍清,李恩.淡豆豉煎剂对高脂血症大鼠主动脉晚期糖化终末产物的抑制作用[J].中药药理与临床,2006,22(3):101-103. 被引量:5
  • 2蔡琨,冯华,田维毅.纯种发酵对淡豆豉主要有效成分的影响[J].甘肃中医学院学报,2006,23(5):39-41. 被引量:22
  • 3MESSINA M. A brief historical overview of the past two decades of soy aad isoflavone research[J]. J Nutr, 2010, 140(7): 1350S-1354S.
  • 4GILBERT E R, LIU D. Flavonoids influence epigenetic-modifying en-zyme activity: structure-function relationships and the therapeutic poten-tial for cancer[J]. Curr Med Chem, 2010, 17(17): 1756-1768.
  • 5LARKIN T, PRICE W E, ASTHEIMER L. The key importance of soy isoflavone bioavailability to understanding health benefits[J]. Crit Rev Food Sci Nutr, 2008, 48(6): 538-552.
  • 6PHAM T T, SHAH N P. Skim milk powder supplementation affects lactose utilization, microbial survival and biotransformation of isoflavone glycosides to isoflavone aglycones in soymilk by Lactobacillus[J]. Food Microbiol, 2008, 25(5): 653-661.
  • 7PHAM T T, SHAH N P. Effects of lactulose supplementation on the growth of bifidobacteria and biotransformation of isoflavone glycosides to isoflavone aglycones in soyrnilk[J]. J Agric Food Chem, 2008, 56 (12): 47034709.
  • 8PHAM TT, SHAH N P. Effect of lactulose on biotransformation of isoflavone glycosides to aglycones in soymilk by lactobacilli[J]. J Food Sci, 2008, 73(3): M158-M165.
  • 9WEBER J M, CONSTANT1NOU A I, HESSLER P E. A Process of preparing genistein: US, 5554519[P]. 1996-09-10.
  • 10UMEZAWA H, TOBE H, SHIBAMOTO N, et al. Isolation of isoflavones inhibiting dopa decarboxylase from fungi and streptomyces[J]. J Antibiotics, 1975, 28(12): 947-952.

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部